These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7495309

  • 1. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin.
    Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM.
    Am J Pathol; 1995 Dec; 147(6):1862-70. PubMed ID: 7495309
    [Abstract] [Full Text] [Related]

  • 2. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
    Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, Mears JG, Zangwill SD, Addonizio LJ, Michler RE, Knowles DM.
    Cancer; 1998 May 15; 82(10):1978-87. PubMed ID: 9587133
    [Abstract] [Full Text] [Related]

  • 3. Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
    Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I.
    Am J Clin Pathol; 1995 Jun 15; 103(6):748-55. PubMed ID: 7785662
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM.
    Am J Pathol; 1997 Sep 15; 151(3):805-12. PubMed ID: 9284829
    [Abstract] [Full Text] [Related]

  • 5. Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.
    Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L, Haskins S, Heerema NA, Gharpure V, Abonour R, Srour EF, Cornetta K.
    Am J Clin Pathol; 1997 Apr 15; 107(4):419-29. PubMed ID: 9124210
    [Abstract] [Full Text] [Related]

  • 6. Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.
    Kinch A, Cavelier L, Bengtsson M, Baecklund E, Enblad G, Backlin C, Thunberg U, Sundström C, Pauksens K.
    Am J Transplant; 2014 Dec 15; 14(12):2838-45. PubMed ID: 25307322
    [Abstract] [Full Text] [Related]

  • 7. Molecular pathology of posttransplantation lymphoproliferative disorders.
    Chadburn A, Cesarman E, Knowles DM.
    Semin Diagn Pathol; 1997 Feb 15; 14(1):15-26. PubMed ID: 9044506
    [Abstract] [Full Text] [Related]

  • 8. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
    Lones MA, Lopez-Terrada D, Shintaku IP, Rosenthal J, Said JW.
    Arch Pathol Lab Med; 1998 Aug 15; 122(8):708-14. PubMed ID: 9701332
    [Abstract] [Full Text] [Related]

  • 9. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM.
    Blood; 1998 Oct 01; 92(7):2294-302. PubMed ID: 9746767
    [Abstract] [Full Text] [Related]

  • 10. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 11. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ, Jiwa M, van den Brule AJ, Grässer FA, Horstman A, Vos W, Kluin PM, van der Valk P, Walboomers JM, Meijer CJ.
    Am J Pathol; 1995 Oct 27; 147(4):923-33. PubMed ID: 7573368
    [Abstract] [Full Text] [Related]

  • 12. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria.
    Canioni D, Jabado N, MacIntyre E, Patey N, Emile JF, Brousse N.
    Histopathology; 2001 Feb 27; 38(2):146-59. PubMed ID: 11207828
    [Abstract] [Full Text] [Related]

  • 13. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L, Lome-Maldonado C, Schwarzmann F, Gredler E, Reyes E, Angeles-Angeles A, Fend F.
    Mod Pathol; 1998 Feb 27; 11(2):200-8. PubMed ID: 9504692
    [Abstract] [Full Text] [Related]

  • 14. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE.
    Blood; 1995 Jan 15; 85(2):552-65. PubMed ID: 7812011
    [Abstract] [Full Text] [Related]

  • 15. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
    Yoon SO, Yu E, Cho YM, Suh C, Kim KM, Han DJ, Lee SG, Huh J.
    Clin Transplant; 2012 Jan 15; 26(1):67-73. PubMed ID: 21269330
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
    Strazzabosco M, Corneo B, Iemmolo RM, Menin C, Gerunda G, Bonaldi L, Merenda R, Neri D, Poletti A, Montagna M, Del Mistro A, Faccioli AM, D'Andrea E.
    J Hepatol; 1997 Apr 15; 26(4):926-34. PubMed ID: 9126809
    [Abstract] [Full Text] [Related]

  • 17. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 15; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 18. Lymphoproliferative disease in organ transplant recipients.
    Nalesnik MA.
    Springer Semin Immunopathol; 1991 Mar 15; 13(2):199-216. PubMed ID: 1664986
    [No Abstract] [Full Text] [Related]

  • 19. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E, Özdemir BH, Yılmaz Akçay E, Terzi A, Karakuş S, Haberal M.
    Exp Clin Transplant; 2015 Apr 15; 13 Suppl 1():183-7. PubMed ID: 25894151
    [Abstract] [Full Text] [Related]

  • 20. Donor Monoclonal Gammopathy May Cause Lymphoproliferative Disorders in Solid Organ Transplant Recipients.
    Felldin M, Ekberg J, Polanska-Tamborek D, Hansson U, Sender M, Rizell M, Svanvik J, Mölne J.
    Am J Transplant; 2016 Sep 15; 16(9):2676-83. PubMed ID: 27575725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.